Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis

Clinical trial NCT01337219 · UNKNOWN

Trial details

NCT number: NCT01337219
Sponsor: Erempharma
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2011-04-01
Primary completion: 2011-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.